|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-4-4
|
|
pubmed:abstractText |
We hypothesized that technetium-99m-ethylene dicysteine-metronidazole (99mTc-EC-MN) localizes to brain tissue that is hypoxic but viable. This study prospectively evaluated the relationship between neurological outcome and uptake of 99mTc-EC-MN in peri-infarcted regions of the brain.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1524-4628
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
34
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
982-6
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12649518-Acute Disease,
pubmed-meshheading:12649518-Aged,
pubmed-meshheading:12649518-Brain,
pubmed-meshheading:12649518-Brain Ischemia,
pubmed-meshheading:12649518-Cysteine,
pubmed-meshheading:12649518-Diffusion Magnetic Resonance Imaging,
pubmed-meshheading:12649518-Female,
pubmed-meshheading:12649518-Humans,
pubmed-meshheading:12649518-Male,
pubmed-meshheading:12649518-Metronidazole,
pubmed-meshheading:12649518-Middle Aged,
pubmed-meshheading:12649518-Middle Cerebral Artery,
pubmed-meshheading:12649518-Nervous System Diseases,
pubmed-meshheading:12649518-Organotechnetium Compounds,
pubmed-meshheading:12649518-Prognosis,
pubmed-meshheading:12649518-Radiopharmaceuticals,
pubmed-meshheading:12649518-Stroke,
pubmed-meshheading:12649518-Tomography, Emission-Computed, Single-Photon
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Prognostication of recovery in patients with acute ischemic stroke through the use of brain SPECT with Technetium-99m--labeled metronidazole.
|
|
pubmed:affiliation |
Department of Nuclear Medicine, Chonnam National University Hospital, 8 Hak-Dong, Dong-Gu, Gwangju, South Korea.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
